PT3250218T - Péptido natkide para o tratamento da obesidade - Google Patents

Péptido natkide para o tratamento da obesidade

Info

Publication number
PT3250218T
PT3250218T PT167441864T PT16744186T PT3250218T PT 3250218 T PT3250218 T PT 3250218T PT 167441864 T PT167441864 T PT 167441864T PT 16744186 T PT16744186 T PT 16744186T PT 3250218 T PT3250218 T PT 3250218T
Authority
PT
Portugal
Prior art keywords
methods
treating obesity
obesity
treating
Prior art date
Application number
PT167441864T
Other languages
English (en)
Original Assignee
Marshall Univ Research Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marshall Univ Research Corporation filed Critical Marshall Univ Research Corporation
Publication of PT3250218T publication Critical patent/PT3250218T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y306/00—Hydrolases acting on acid anhydrides (3.6)
    • C12Y306/03—Hydrolases acting on acid anhydrides (3.6) acting on acid anhydrides; catalysing transmembrane movement of substances (3.6.3)
    • C12Y306/03009—Na+/K+-exchanging ATPase (3.6.3.9)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT167441864T 2015-01-30 2016-01-29 Péptido natkide para o tratamento da obesidade PT3250218T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562109816P 2015-01-30 2015-01-30

Publications (1)

Publication Number Publication Date
PT3250218T true PT3250218T (pt) 2021-05-14

Family

ID=56544393

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167441864T PT3250218T (pt) 2015-01-30 2016-01-29 Péptido natkide para o tratamento da obesidade

Country Status (7)

Country Link
US (1) US11311600B2 (pt)
EP (1) EP3250218B1 (pt)
CN (1) CN107249614B (pt)
DK (1) DK3250218T3 (pt)
ES (1) ES2868354T3 (pt)
PT (1) PT3250218T (pt)
WO (1) WO2016123493A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200157568A1 (en) * 2017-05-26 2020-05-21 Marshall University Research Corporation EXPRESSION VECTORS AND RELATED METHODS OF DELIVERY OF Na/K ATPASE/Src RECEPTOR COMPLEX ANTAGONISTS
EP4364749A1 (en) * 2021-06-28 2024-05-08 Korea University Research and Business Foundation Peptide having obesity and muscle loss inhibitory activities, and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2544099A1 (en) * 2003-10-28 2005-05-06 Protemix Discovery Limited Peptides with anti-obesity activity and other related uses
US20060094682A1 (en) * 2004-10-29 2006-05-04 Odyssey Thera, Inc. Kinase inhibitors for the treatment of diabetes and obesity
US20100048545A1 (en) 2006-03-22 2010-02-25 Innodia Inc. Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
CN101541319B (zh) 2006-10-31 2013-09-18 托莱多大学 Src和Src家族激酶的Na+/K+-ATP酶特异性肽抑制剂/激活剂
EP2361097A4 (en) * 2008-12-12 2012-04-25 Univ Toledo SCR-HEMMER WITH PEPTIDES DERIVED FROM NA / K ATPASE AND OUABINE ANTAGONISTS AND APPLICATIONS THEREOF
CA2774486C (en) 2009-09-16 2019-06-04 The University Of Toledo Hydroxy xanthone-based na/k atpase ligands useful in treating cardiac hypertrophy, and congestive heart failure
US8691947B2 (en) 2010-01-13 2014-04-08 The University Of Toledo Materials related to sodium/potassium adenosine triphosphatase and Src
US8899407B2 (en) 2010-08-03 2014-12-02 J&L Group International, Llc System and method for orienting bundles
WO2013169931A2 (en) 2012-05-08 2013-11-14 The University Of Toledo Assays and cell-based tests using a receptor na/k-atpase/src complex and uses thereof

Also Published As

Publication number Publication date
EP3250218A1 (en) 2017-12-06
US20180353569A1 (en) 2018-12-13
EP3250218A4 (en) 2018-10-17
ES2868354T3 (es) 2021-10-21
CN107249614B (zh) 2021-06-22
US11311600B2 (en) 2022-04-26
DK3250218T3 (da) 2021-05-17
EP3250218B1 (en) 2021-04-14
CN107249614A (zh) 2017-10-13
WO2016123493A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
HK1251407A1 (zh) 治療癌症的方法
IL304252A (en) Cancer treatment methods
IL289947A (en) A method for treating cancer
IL279308A (en) Methods for the treatment of heptidine-mediated disorders
HK1244217A1 (zh) 用於治療蛋白質病的方法
HK1245804A1 (zh) 用於治療pvns的抗csf1r抗體
HK1250944A1 (zh) 用於治療癌症的方法
GB2580236B (en) Apparatus for treating runoff
IL249936A0 (en) Methods for treating hypotension
IL249475A0 (en) Methods for treating itching
HK1255481A1 (zh) 用於治療hcv的方法
IL246558A0 (en) New methods of cancer treatment
HK1250942A1 (zh) 用於治療癌症的方法
HK1250943A1 (zh) 用於治療癌症的方法
EP3302695C0 (en) MUSCLE TREATMENT DEVICES
PT3250218T (pt) Péptido natkide para o tratamento da obesidade
ZA201607068B (en) Methods for treating hypersomnia
IL249616A0 (en) Methods for treating inflammation